Beijing King Health to Distribute Allium Medical Devices in China

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 6, 2013 -- Allium Medical of Israel signed up Beijing King Health Investment to distribute the company's urinary tract stents in China. King Health agreed to buy at least $16 million of Allium's stents during the eight-year run of the contract. The two companies expect to launch the urinary stents in 2016, assuming CFDA approval. More details....

Stock Symbol: (TASE: ALMD)

Help employers find you! Check out all the jobs and post your resume.

Back to news